137 related articles for article (PubMed ID: 1391487)
1. Characteristics of polylipid/Hb vesicles (ARC) (in vitro and in vivo test).
Nakachi O; Tokuyama S; Satoh T; Tsuchida E
Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):635-40. PubMed ID: 1391487
[TBL] [Abstract][Full Text] [Related]
2. Stability and blood compatibility of polylipid/Hb.
Morizawa K; Akama K; Kawakami Y; Tsuchida E
Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):641-5. PubMed ID: 1391488
[TBL] [Abstract][Full Text] [Related]
3. Oxygen transport and in vivo parameters of artificial red cells (ARC).
Akama K; Morizawa K; Tokuyama S; Satoh T; Kobayashi K; Sekiguchi S; Tsuchida E
Artif Cells Blood Substit Immobil Biotechnol; 1994; 22(3):901-7. PubMed ID: 7994416
[TBL] [Abstract][Full Text] [Related]
4. Oxygen-transport and solution properties of polylipid/Hb vesicles (ARC).
Takeoka S; Hasegawa E; Nishide H; Tsuchida E; Sekiguchi S
Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):399-404. PubMed ID: 1391455
[TBL] [Abstract][Full Text] [Related]
5. Characteristics of artificial red cells. Hemoglobin encapsulated in poly-lipid vesicles.
Satoh T; Kobayashi K; Sekiguchi S; Tsuchida E
ASAIO J; 1992; 38(3):M580-4. PubMed ID: 1457926
[TBL] [Abstract][Full Text] [Related]
6. Characteristics of neo red cells, their function and safety: in vivo studies.
Ogata Y; Goto H; Sakaguchi K; Suzuki M; Ohsaki K; Suzuki K; Saniabadi AR; Kamitani T; Takahashi A
Artif Cells Blood Substit Immobil Biotechnol; 1994; 22(3):875-81. PubMed ID: 7994412
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and characterization of artificial red cell (ARC).
Tsuchida E
Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):337-44. PubMed ID: 1391449
[TBL] [Abstract][Full Text] [Related]
8. Performances of PEG-modified hemoglobin-vesicles as artificial oxygen carriers in microcirculation.
Sakai H; Tsuchida E
Clin Hemorheol Microcirc; 2006; 34(1-2):335-40. PubMed ID: 16543654
[TBL] [Abstract][Full Text] [Related]
9. Characteristics of Hb-vesicles and encapsulation procedure.
Takeoka S; Sakai H; Terase K; Nishide H; Tsuchida E
Artif Cells Blood Substit Immobil Biotechnol; 1994; 22(3):861-6. PubMed ID: 7994410
[TBL] [Abstract][Full Text] [Related]
10. [Human infusion of perfluorocarbons as blood substitutes].
Ivanov KP
Gematol Transfuziol; 1984 Jul; 29(7):40-7. PubMed ID: 6381221
[No Abstract] [Full Text] [Related]
11. Hemoglobin vesicles, polyethylene glycol (PEG)ylated liposomes developed as a red blood cell substitute, do not induce the accelerated blood clearance phenomenon in mice.
Taguchi K; Urata Y; Anraku M; Watanabe H; Kadowaki D; Sakai H; Horinouchi H; Kobayashi K; Tsuchida E; Maruyama T; Otagiri M
Drug Metab Dispos; 2009 Nov; 37(11):2197-203. PubMed ID: 19679674
[TBL] [Abstract][Full Text] [Related]
12. Liposome-encapsulated hemoglobin using film hydration processing to form artificial red blood cells.
Deshpande SV; Beissinger RL
Biomater Artif Cells Immobilization Biotechnol; 1993; 21(2):135-51. PubMed ID: 8318608
[TBL] [Abstract][Full Text] [Related]
13. Hepatically-metabolized and -excreted artificial oxygen carrier, hemoglobin vesicles, can be safely used under conditions of hepatic impairment.
Taguchi K; Miyasato M; Ujihira H; Watanabe H; Kadowaki D; Sakai H; Tsuchida E; Horinouchi H; Kobayashi K; Maruyama T; Otagiri M
Toxicol Appl Pharmacol; 2010 Nov; 248(3):234-41. PubMed ID: 20709091
[TBL] [Abstract][Full Text] [Related]
14. The oxygen carrying capability of hemoglobin vesicles evaluated in rat exchange transfusion models.
Kobayashi K; Izumi Y; Yoshizu A; Horinouchi H; Park SI; Sakai H; Takeoka S; Nishide H; Tsuchida E
Artif Cells Blood Substit Immobil Biotechnol; 1997 Jul; 25(4):357-66. PubMed ID: 9242931
[TBL] [Abstract][Full Text] [Related]
15. The ability of polyethylene glycol conjugated bovine hemoglobin (PEG-Hb) to adequately deliver oxygen in both exchange transfusion and top-loaded rat models.
Conover CD; Linberg R; Shum KL; Shorr RG
Artif Cells Blood Substit Immobil Biotechnol; 1999 Mar; 27(2):93-107. PubMed ID: 10092932
[TBL] [Abstract][Full Text] [Related]
16. PEG-hemoglobin: an efficient oxygen-delivery system in the rat exchange transfusion and hypovolemic shock models.
Nho K; Linberg R; Johnson M; Gilbert C; Shorr R
Artif Cells Blood Substit Immobil Biotechnol; 1994; 22(3):795-803. PubMed ID: 7994402
[TBL] [Abstract][Full Text] [Related]
17. Progress in development of synthetic erythrocytes made by encapsulation of hemoglobin.
Djordjevich L; Ivankovich AD
Adv Exp Med Biol; 1988; 238():171-97. PubMed ID: 3074636
[No Abstract] [Full Text] [Related]
18. Surface modification of hemoglobin vesicles with poly(ethylene glycol) and effects on aggregation, viscosity, and blood flow during 90% exchange transfusion in anesthetized rats.
Sakai H; Takeoka S; Park SI; Kose T; Nishide H; Izumi Y; Yoshizu A; Kobayashi K; Tsuchida E
Bioconjug Chem; 1997; 8(1):23-30. PubMed ID: 9026031
[TBL] [Abstract][Full Text] [Related]
19. Liposome-encapsulated hemoglobin as a red cell surrogate. Preparation scale-up.
Beissinger RL; Farmer MC; Gossage JL
ASAIO Trans; 1986; 32(1):58-63. PubMed ID: 3778774
[No Abstract] [Full Text] [Related]
20. Metabolism of hemoglobin-vesicles (artificial oxygen carriers) and their influence on organ functions in a rat model.
Sakai H; Horinouchi H; Masada Y; Takeoka S; Ikeda E; Takaori M; Kobayashi K; Tsuchida E
Biomaterials; 2004 Aug; 25(18):4317-25. PubMed ID: 15046922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
